Position history for ProShare Advisors LLC's holdings in ACADIA PHARMACEUTICAL
ProShare Advisors LLC holds 27,197 shares of ACAD (ACADIA PHARMACEUTICAL), worth $605,406 as of 2026-Q1. The position was decreased (-14.2% shares). ACAD represents 0.0% of ProShare Advisors LLC's portfolio.
Current Value
$605,406
Current Shares
27,197
Total Value Change
+$172,732
Total Shares Change
+571
Other major holders of ACAD: BAKER BROS. ADVISORS LP
Decreased |
| 27,197 |
-14.2% |
| $605,406 |
| 0.0% |
| $22.50 |
0 |
| 2025-Q4 | Increased | 31,678 | +7.5% | $846,119 | 0.0% | $26.70 | 27 |
| 2025-Q3 | Decreased | 29,463 | -13.4% | $628,740 | 0.0% | $21.32 | 0 |
| 2025-Q2 | Decreased | 34,016 | -4.9% | $733,725 | 0.0% | $22.12 | 0 |
| 2025-Q1 | Decreased | 35,769 | -14.0% | $594,123 | 0.0% | $17.07 | 0 |
| 2024-Q4 | Increased | 41,580 | +28.3% | $762,993 | 0.0% | $16.69 | 31 |
| 2024-Q3 | Increased | 32,416 | +21.8% | $498,558 | 0.0% | $15.69 | 29 |
| 2024-Q2 | Decreased | 26,626 | -20.7% | $432,674 | 0.0% | $16.25 | 0 |